Celeste Lebbe

Celeste Lebbe

UNVERIFIED PROFILE

Are you Celeste Lebbe?   Register this Author

Register author
Celeste Lebbe

Celeste Lebbe

Publications by authors named "Celeste Lebbe"

Are you Celeste Lebbe?   Register this Author

100Publications

9825Reads

18Profile Views

Recurrence of Immune-Mediated Colitis Upon Immune Checkpoint Inhibitor Resumption: Does Time Matter?

J Clin Oncol 2019 Oct 9:JCO1901891. Epub 2019 Oct 9.

Julie Delyon, MD, PhD, Hôpital Saint-Louis, Paris, France, and Université de Paris, Paris, France; Nelson Lourenço, MD; Lan-Trang Vu, PhD; Clara Allayous, PhD; and Barouyr Baroudjian, MD, Hôpital Saint-Louis, Paris, France; and Celeste Lebbe, MD, PhD, Hôpital Saint-Louis, Paris, France, and Université de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01891DOI Listing
October 2019

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

N Engl J Med 2019 Sep 28. Epub 2019 Sep 28.

From the Royal Marsden NHS Foundation Trust, London (J.L.), and the College of Medicine, Swansea University, Swansea (J.W.) - both in the United Kingdom; the Oncology Institute of Veneto IRCCS, Padua (V.C.-S.), the European Institute of Oncology, IRCCS, Milan (P.F.F.), Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and the Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital, Siena (M.M.) - all in Italy; the University of Colorado Cancer Center, Aurora (R.G.); Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille Hôpital Timone, Marseille (J.-J.G.), and Université de Paris, INSERM Unité 976, Assistance Publique-Hôpitaux de Paris Dermatology and Centres d'Investigation Clinique, Saint Louis Hospital, Paris (C.L.) - both in France; the Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); the University of Michigan, Ann Arbor (C.D.L.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.); Universitäts Spital, Zurich, Switzerland (R.D.); Cross Cancer Institute, Edmonton, AB (M.S.), and the Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.H.), the Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney, Sydney, NSW (M.S.C., G.V.L.), and the Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and the Peter MacCallum Cancer Centre, Melbourne, VIC (G.M.) - all in Australia; General University Hospital Gregorio Marañon and Centro de Investigación Biomédica en Red de Oncología, Madrid (I.M.-R.); the Netherlands Cancer Institute, Amsterdam (J.H.); the Leuven Cancer Institute, Department of General Medical Oncology, University Hospital Leuven, Leuven, Belgium (P.S.); University of California San Diego Health-La Jolla Moores Cancer Center, La Jolla (G.A.D.); the Department of Oncology, Odense University Hospital, Odense, Denmark (L.B.); Bristol-Myers Squibb, Princeton, NJ (J.I.R., A.B., A.M.); Dana-Farber Cancer Institute, Boston (F.S.H.); and the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1910836DOI Listing
September 2019

Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study.

J Am Acad Dermatol 2019 Aug 19;81(2):448-455. Epub 2019 Mar 19.

Department of Dermatology, Assistance Publique-Hôpitaux de Paris (AP-HP) Hôpital Saint Louis, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.03.028DOI Listing
August 2019

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.

N Engl J Med 2019 08 4;381(7):626-636. Epub 2019 Jun 4.

From Institut Gustave Roussy and Paris-Sud-Paris-Saclay University, Villejuif (C.R.), Aix-Marseille University, Marseille (J.J.G.), and Assistance Publique-Hôpitaux de Paris Dermatology and Clinical Investigation Center, Unité 976, Université de Paris, Hôpital Saint-Louis, Paris (C.L.) - all in France; Moscow City Oncology Hospital, Moscow (D. Stroyakovskiy), and the Petrov Research Institute of Oncology, St. Petersburg (E.L.) - both in Russia; Przychodnia Lekarska Komed, Konin (B.K.), the University of Medical Sciences, Poznań (A.M.), and the Maria Skłodowska-Curie Institute-Oncology Center, Warsaw (P.R.) - all in Poland; the University Hospital Schleswig-Holstein, Kiel (A.H.), the Department of Dermatology, University of Tübingen, Tübingen (C.G.), University Hospital Essen, Essen (D. Schadendorf), and the German Cancer Consortium, Heidelberg (D. Schadendorf) - all in Germany; the Veneto Institute of Oncology, Padua (V.C.S.), and Papa Giovanni XXIII Hospital, Bergamo (M.M.) - both in Italy; the Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Sheba Medical Center, Tel Hashomer (J.S.), and Sackler Medical School, Tel Aviv University, Tel Aviv (J.S.) - both in Israel; Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine (I.B.); Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens (H.G.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); Mount Vernon Cancer Centre, Northwood, United Kingdom (P.D.N.); the University of California, Los Angeles, Los Angeles (A.R.); the University of Texas M.D. Anderson Cancer Center, Houston (M.A.D.); Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (K.T.F.); Novartis Pharma, Basel, Switzerland (P.B.); Novartis Pharmaceuticals, East Hanover, NJ (M.T., E.G., M.V.); and the Melanoma Institute Australia, the University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1904059DOI Listing
August 2019

Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series.

Eur J Cancer 2019 Aug 3;117:116-118. Epub 2019 Jul 3.

Dermatology, AP-HP Hopital Saint-Louis, Paris, France; Université de Paris, INSERM HIPI, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.05.022DOI Listing
August 2019

Atypical and Mutations in Mucosal Melanoma.

Cancers (Basel) 2019 Aug 8;11(8). Epub 2019 Aug 8.

INSERM, U976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11081133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721527PMC
August 2019

Checkpoint inhibitor treatment induces an increase in HbA1c in nondiabetic patients.

Melanoma Res 2019 06;29(3):328-332

AP-HP Department of Diabetology, INSERM U1138, Lariboisiére Hospital, Université Paris Diderot - Paris VII, Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000585DOI Listing
June 2019

Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas.

Cancer Immunol Immunother 2019 Jun 5;68(6):951-960. Epub 2019 Apr 5.

Pathology Department, INSERM UMR_S1165, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris (APHP), 1 Avenue Claude Vellefaux, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-019-02334-8
Publisher Site
http://dx.doi.org/10.1007/s00262-019-02334-8DOI Listing
June 2019

Rechallenge of immune checkpoint inhibitor after pembrolizumab-induced myasthenia gravis.

Eur J Cancer 2019 May 12;113:72-74. Epub 2019 Apr 12.

Department of Dermatology, APHP Saint Louis Hospital, Paris, France; Université Paris 7 Diderot, Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.03.006DOI Listing
May 2019

New Vision in Photoprotection and Photorepair.

Dermatol Ther (Heidelb) 2019 Mar 23;9(1):103-115. Epub 2019 Jan 23.

Policlinique de Dermatologie, Hôpital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13555-019-0282-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380982PMC
March 2019

New perspectives in Merkel cell carcinoma.

Curr Opin Oncol 2019 Mar;31(2):72-83

APHP, Department of Dermatology, Saint-Louis Hospital, Sorbonne Paris Cité Université, Paris Diderot, INSERM U976, Paris, France.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00001622-900000000-9921
Publisher Site
http://dx.doi.org/10.1097/CCO.0000000000000508DOI Listing
March 2019

[Update in treatment for Merkel Cell Carcinoma and clinical practice guide].

Bull Cancer 2019 Jan 19;106(1):64-72. Epub 2018 Dec 19.

AP-HP Dermatology, hôpital Saint-Louis, Paris 7 Diderot University, Department of Dermatology, Inserm U976, 1, avenue Claude-Vellefaux, 75010 Paris, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551183036
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2018.11.009DOI Listing
January 2019

Ipilimumab for the treatment of advanced melanoma in six kidney transplant patients.

Am J Transplant 2018 12 21;18(12):3065-3071. Epub 2018 Sep 21.

APHP Dermatology department, INSERM U976, University Paris Diderot, Saint-Louis Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajt.15071DOI Listing
December 2018

Osteopenia and fractures associated with long-term therapy with MEK inhibitors.

Melanoma Res 2018 12;28(6):641-644

Hôpital Lariboisière, Department of Rheumatology, Inserm UMR 1132, Université Paris Diderot, Sorbonne Paris Cité, AP-HP.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000490DOI Listing
December 2018

Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe.

Eur J Dermatol 2018 Dec;28(6):736-749

Skin Cancer Centre/Dermatology Clinic, Universitätsspital Zürich, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/ejd.2018.3447DOI Listing
December 2018

Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?

J Hepatol 2018 08 7;69(2):548-550. Epub 2018 May 7.

AP-HP, Département de Dermatologie Hôpital Saint-Louis, Paris, France; INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.03.034DOI Listing
August 2018

Assessing cognitive function in patients treated with immune checkpoint inhibitors: A feasibility study.

Psychooncology 2018 07 19;27(7):1861-1864. Epub 2018 Apr 19.

Service de Neurologie, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pon.4725
Publisher Site
http://dx.doi.org/10.1002/pon.4725DOI Listing
July 2018

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.

J Clin Oncol 2018 06 5;36(17):1658-1667. Epub 2017 Oct 5.

Jason Chesney, J. Graham Brown Cancer Center, University of Louisville, Louisville, KY; Igor Puzanov, Roswell Park Cancer Institute, Buffalo; Philip Friedlander, Mt Sinai School of Medicine, New York, NY; Frances Collichio, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Parminder Singh, Mayo Clinic, Phoenix, AZ; Mohammed M. Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA; John Glaspy, University of California Los Angeles School of Medicine; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Lisa Chen, Jenny J. Kim, and Jennifer Gansert, Amgen, Thousand Oaks, CA; Merrick Ross, MD Anderson Cancer Center, Houston, TX; Claus Garbe, University Hospital Tuebingen, Tuebingen; Axel Hauschild, University of Kiel, Kiel, Germany; Theodore F. Logan, Indiana University Simon Cancer Center, Indianapolis, IN; Celeste Lebbé, Assistance Publique-Hôpital De Paris Dermatology and CIC Hôpital Saint Louis University Paris Diderot Sorbonne, Institut National de la Santé et de la Recherche Médicale U976, Paris, France; Robert H.I. Andtbacka, University of Utah, Salt Lake City, UT; and Howard L. Kaufman, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.73.7379
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.73.7379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075852PMC
June 2018

Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.

Genes Chromosomes Cancer 2018 Jun 21;57(6):294-303. Epub 2018 Feb 21.

INSERM U976, Centre de Recherche sur la Peau, Hôpital Saint Louis, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22528DOI Listing
June 2018

Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma.

Eur J Cancer 2018 04 12;93:147-149. Epub 2018 Feb 12.

APHP Dermatology, Department of Dermatology and CIC, Paris 7 Diderot University, INSERM U976, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.01.062DOI Listing
April 2018

STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network.

J Invest Dermatol 2018 01 24;138(1):58-67. Epub 2017 Aug 24.

Service de Dermatologie, and CIC (Centre d'Investigations Cliniques), AP-HP, Hôpital Saint-Louis, Paris, France; INSERM, UMR-976, AP-HP, Hôpital Saint-Louis, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.07.839DOI Listing
January 2018

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma.

J Clin Oncol 2017 Dec 15;35(34):3815-3822. Epub 2017 Sep 15.

Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT; Pier Francesco Ferrucci, Istituto Europeo di Oncologia, Milan; Massimo Guidoboni, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy; David Hogg, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Pascal Wolter, University Hospitals Leuven, Leuven, Belgium; Celeste Lebbé, Université Paris Diderot, Paris; Luc Thomas, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France; John M. Kirkwood, Hillman Cancer Center, Pittsburgh, PA; Jacob Schachter, Sheba Medical Center, Ramat Gan, Israel; Gregory A. Daniels, University of California San Diego, Moores Cancer Center, La Jolla, CA; Jessica Hassel, University Hospital, Heidelberg, Germany; Jonathan Cebon, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria; Winald Gerritsen, University of Queensland, St Lucia; Victoria Atkinson, Gallipoli Medical Research Foundation, Greenslopes; Victoria Atkinson, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Winald Gerritsen, Radboud University Medical Center, Nijmegen, the Netherlands; John McCaffrey, Irish Clinical Oncology Research Group, Dublin; Derek Power, Irish Clinical Oncology Research Group, Cork, Ireland; Dana Walker, Rafia Bhore, and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; and Jedd D. Wolchok, Parker Institute and Ludwig Center at Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.1167DOI Listing
December 2017

Transient pituitary ACTH-dependent Cushing syndrome caused by an immune checkpoint inhibitor combination.

Melanoma Res 2017 12;27(6):649-652

aAP-HP, Department of Dermatology bINSERM_U976, Department of Dermatology cAP-HP, CIC Department dAP-HP, Department of Radiology, Saint-Louis Hospital eAP-HP, Department of Diabetes and Endocrinology, DHU FIRE, Lariboisiere Hospital fParis-Diderot, Sorbonne Paris Cité University gAP-HP, Department of Endocrinology, Bicetre Hospital, University Paris-Sud, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000405DOI Listing
December 2017

Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors.

Ann Intern Med 2017 Nov 5;167(9):683-684. Epub 2017 Sep 5.

From Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard Hospital, Saint-Louis Hospital, and Saint-Antoine Hospital; Université Paris Diderot; Sorbonne Paris Cité; and Institut National de la Santé et de la Recherche Médicale, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/L17-0396DOI Listing
November 2017

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.

N Engl J Med 2017 11 10;377(19):1824-1835. Epub 2017 Sep 10.

From New York University Perlmutter Cancer Center, New York (J.W.); Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; National and Kapodistrian University of Athens, Athens (H.J.G.); Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France; Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker); Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada; the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia; University of Colorado, Denver (R.G.); Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.); Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.); University of Washington, Seattle (S.B.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan; Seoul National University Hospital, Seoul, South Korea (T.M.K.); and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709030DOI Listing
November 2017

Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.

Eur J Cancer 2017 11 4;86:115-124. Epub 2017 Oct 4.

Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, La Trobe University, 145 Studley Road, Heidelberg VIC 3084, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.08.032DOI Listing
November 2017

Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab.

Semin Arthritis Rheum 2017 10 8;47(2):281-287. Epub 2017 Mar 8.

Dermatology Department, INSERM U976, Saint-Louis Hospital, Sorbonne Paris Cité, Université Paris Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2017.03.003DOI Listing
October 2017

Bortezomib Does Not Prevent the Occurrence of Kaposi's Sarcoma in Patients with Haematological Malignancies: Two Case Reports.

Acta Derm Venereol 2017 Oct;97(9):1138-1139

Nephrology Department, Hôpital Européen Georges Pompidou, 20, rue Leblanc, FR-75015 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-2727DOI Listing
October 2017

Focal necrotizing myopathy with 'dropped-head syndrome' induced by cobimetinib in metastatic melanoma.

Melanoma Res 2017 10;27(5):511-515

aAPHP, Dermatology Department bAPHP, Pharmacology Department cAPHP, Pharmacogenomic Laboratory dAPHP, Pathology Department eAPHP, Nuclear Medicine Department, Saint-Louis Hospital fAPHP, Neuropathology Laboratory gAPHP, Reference Center of Neuro-muscular Disease, Pitié Salpétrière Hospital hUniversité Paris VI Pierre et Marie Curie, Paris iINSERM U976 jINSERM U1165 kUniversité Paris Diderot-Paris VII, Sorbonne Paris Cité, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000377DOI Listing
October 2017

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

N Engl J Med 2017 10 11;377(14):1345-1356. Epub 2017 Sep 11.

From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; University of Colorado, Denver (R.G.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); University of Michigan, Ann Arbor (C.D.L.); the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.); Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada; Universitäts Spital, Zurich, Switzerland (R.D.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia; Netherlands Cancer Institute, Amsterdam (J.H.); University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.); General University Hospital Gregorio Marañón, Madrid (I.M.-R.); Northwestern University, Chicago (J.S.); Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.); and the Dana-Farber Cancer Institute, Boston (F.S.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706778PMC
October 2017

Merkel cell carcinoma.

Nat Rev Dis Primers 2017 Oct 26;3:17077. Epub 2017 Oct 26.

Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrdp201777
Publisher Site
http://dx.doi.org/10.1038/nrdp.2017.77DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054450PMC
October 2017

Sebaceous Carcinomas of the Skin: 24 Cases and a Literature Review.

Acta Derm Venereol 2017 Aug;97(8):959-961

Department of Dermatology and Venereology, Université Paris 7, Saint Louis Hospital, FR-75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-2685DOI Listing
August 2017

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients.

Melanoma Res 2017 04;27(2):110-115

aDepartment of Dermatology, Saint-Louis Hospital bMelBase, Assistance publique hôpitaux de Paris cCRESS UMR 1153, Centre de recherche épidémiologie et statistique Sorbonne Paris cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000313DOI Listing
April 2017

Risk of Aggressive Skin Cancers After Kidney Retransplantation in Patients With Previous Posttransplant Cutaneous Squamous Cell Carcinomas: A Retrospective Study of 53 Cases.

Transplantation 2017 Apr;101(4):e133-e141

1 Department of Dermatology, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France. 2 Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands. 3 Hospices Civils de Lyon, Pôle Information Médicale Evaluation Recherche, Unité de Recherche Clinique, Lyon, France. 4 Université de Lyon, Laboratoire Santé Individu Société, Lyon, France. 5 Department of Dermatology, Nantes University Medical Center, Nantes, France. 6 Department of Dermatology, Saint Louis Hospital, APHP, University Paris VII, Paris, France. 7 Department of Dermatology, Tenon Hospital, APHP, University Paris VI, Paris, France. 8 Department of Transplantation and Nephrology, Edouard Herriot Hospital, Université de Lyon, Lyon, France. 9 Department of Nephrology-Transplantation, Necker Hospital, APHP, Paris, France. 10 Department of Dermatology, Charles-Nicolle University Medical Center, Rouen, France. 11 Department of Renal Medicine and Transplantation, Nantes University Medical Center, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000001644DOI Listing
April 2017

Development and Validation of a Simultaneous Quantification Method of 14 Tyrosine Kinase Inhibitors in Human Plasma Using LC-MS/MS.

Ther Drug Monit 2017 02;39(1):43-54

Departments of *Pharmacology and †Pharmacy, AP-HP, Hôpital Saint-Louis; ‡INSERM UMR_S976, Université Paris-Diderot, Sorbonne Paris Cité; and Departments of §Dermatology and ¶Hematology, AP-HP, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000357DOI Listing
February 2017

Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.

AIDS Res Hum Retroviruses 2017 01 7;33(1):1-10. Epub 2016 Sep 7.

5 INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP UMR 1136), Sorbonne Universités , UPMC Univ Paris 06, Paris, France .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/AID.2016.0069DOI Listing
January 2017

Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs.

Eur J Cancer 2017 01 14;71:53-69. Epub 2016 Dec 14.

Translational Skin Cancer Research (TSCR), German Cancer Consortium Partner Site Essen/Düsseldorf, Dermatology, Essen University Hospital, Essen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.10.022DOI Listing
January 2017

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.

J Clin Oncol 2017 Jan 7;35(2):226-235. Epub 2016 Nov 7.

Sandra P. D'Angelo, Alexander N. Shoushtari, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; James Larkin, Royal Marsden Hospital, London; Paul Lorigan, University of Manchester, Manchester, United Kingdom; Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN; Celeste Lebbé, Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris; Julie Charles, Grenoble University Hospital, Grenoble Alps University, Grenoble, France; Benjamin Brady, Cabrini Health, Melbourne, Australia; Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium; Henrik Schmidt, Århus University, Åarhus, Denmark; Jessica C. Hassel, University Hospital Heidelberg, Heidelberg; Peter Mohr, Elbe Kliniken Buxtehude, Buxtehude; Martin Kaatz, SRH Waldklinikum Gera, University Hospital Jena, Jena, Germany; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Kerry J. Savage, BC Cancer Agency, University of British Columbia, Vancouver; Wilson H. Miller Jr, Lady Davis Institute and Jewish General Hospital, McGill University, Montreal, Canada; Ivan Marquez-Rodas, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Jeffrey S. Weber, Moffitt Cancer Center, Tampa, FL; and Mary Ruisi and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.67.9258
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.67.9258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559888PMC
January 2017

Usual-type vulvar intraepithelial neoplasia: report of a case and its dermoscopic features.

Int J Dermatol 2016 Dec 15;55(12):e621-e623. Epub 2016 Jul 15.

Department of Dermatology, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.13370DOI Listing
December 2016

PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma.

Oncotarget 2016 11;7(45):72961-72977

Institut National de Recherche Médicale (INSERM) UMR1149, Centre de Recherche Sur l'Inflammation, Équipe Immunité Innée Chez l'Enfant, Hôpital Robert Debré, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12150DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341956PMC
November 2016

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.

N Engl J Med 2016 11 7;375(19):1845-1855. Epub 2016 Oct 7.

From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France; the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy; University of Zurich Hospital, Zurich, Switzerland (R.D.); Memorial Sloan Kettering Cancer Center, New York (J.D.W.); Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark; the Angeles Clinic and Research Institute, Los Angeles (O.H.); Oncology Specialists, Park Ridge, IL (J.M.R.); Cross Cancer Institute, Edmonton, AB, Canada (M.S.); H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.); Broomfield Hospital, Chelmsford, United Kingdom (S.T.); Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany; Dana-Farber Cancer Institute, Boston (F.S.H.); Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.); and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1611299DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648545PMC
November 2016

Relevance of serum biomarkers associated with melanoma during follow-up of anti-CTLA-4 immunotherapy.

Int Immunopharmacol 2016 Nov 8;40:466-473. Epub 2016 Oct 8.

INSERM UMR-1160, Institut Universitaire d'Hématologie, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2016.09.030DOI Listing
November 2016

Immunothérapie et mélanome : l’exemple des anticorps immunomodulateurs.

Bull Cancer 2016 Nov;103 Suppl 1:S132-S137

Service de dermatologie, Hôpital saint Louis, 1 av Claude Vellefaux 75010 Paris, 0142385312.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(16)30370-8DOI Listing
November 2016

ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors.

EMBO Mol Med 2016 10 4;8(10):1143-1161. Epub 2016 Oct 4.

Cancer Research Center of Lyon, INSERM U1052, Lyon, France Cancer Research Center of Lyon, CNRS UMR 5286, Lyon, France Université de Lyon, Lyon, France ISPB Université Lyon 1, Lyon, France Centre Léon Bérard, Lyon, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15252/emmm.201505971DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048365PMC
October 2016

Pigmented Bowen's disease presenting with a "starburst" pattern.

Dermatol Pract Concept 2016 Oct 31;6(4):47-49. Epub 2016 Oct 31.

Department of Dermatology, Hôpital Saint-Louis, Université Paris 7 Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5826/dpc.0604a11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108647PMC
October 2016

An unusual case of primary cutaneous Ewing sarcoma in an adult.

Int J Dermatol 2016 Aug 3;55(8):906-8. Epub 2016 Mar 3.

Department of Dermatology, University Hospital, Caen, Basse-Normandie, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.13158DOI Listing
August 2016

Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response.

Oncoimmunology 2016 Jul 18;5(7):1136045. Epub 2016 Feb 18.

INSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Laboratoire d'Immunologie-Histocompatibilité, AP-HP, Hôpital Saint Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1136045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006913PMC
July 2016

Anti-PD1-induced collagenous colitis in a melanoma patient.

Melanoma Res 2016 06;26(3):308-11

Departments of aDermatology bGastroenterology cPathology, Saint-Louis Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000252DOI Listing
June 2016

Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis.

Eur Respir J 2016 06 13;47(6):1785-96. Epub 2016 Apr 13.

Assistance Publique - Hôpitaux de Paris, Centre National de Référence de l'Histiocytose Langerhansienne, Service de Pneumologie, Hôpital Saint-Louis, Paris, France Université Paris-Diderot, Sorbonne Paris Cité; INSERM UMR 1153 CRESS, Equipe de Recherche en Biostatistiques et Epidémiologie Clinique, Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01677-2015DOI Listing
June 2016

Treatment patterns of advanced malignant melanoma (stage III-IV) - A review of current standards in Europe.

Eur J Cancer 2016 06 22;60:179-89. Epub 2016 Apr 22.

Klinik für Dermatologie, Universitätsklinikum Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.01.011DOI Listing
June 2016

Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma.

Chest 2016 May;149(5):e133-6

Dermatology Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Clinical Investigation Department, Assistance Publique - Hôpitaux de Paris, Saint Louis Hospital, Paris, France; Onco-Dermatology, Immunology and Cutaneous Stem Cells, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2015.10.082DOI Listing
May 2016

[Melanoma, from diagnosis to treatment].

Rev Infirm 2016 Mar(219):16-8

Unité d'oncodermatologie, service de dermatologie du Professeur Bagot, Hôpital Saint-Louis, 1 avenue Claude-Vellefaux, 75010, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.revinf.2015.12.022DOI Listing
March 2016